Company Filing History:
2 out of 16 
1 out of 260 
1 out of 542 
Years Active: 2012-2020
Title: The Innovations of Eun-Hee Lee: Pioneering Cancer Treatment Antibodies
Introduction: Eun-Hee Lee, based in Yongin-si, South Korea, is an accomplished inventor recognized for his contributions to the field of biomedical research. With a portfolio of three patents, he has made significant strides in developing innovative antibodies for cancer treatment.
Latest Patents: Among his notable patents, Eun-Hee Lee's invention of the "Anti-mesothelin antibody and composition comprising the same" stands out. This antibody specifically binds to mesothelin (MSLN), a critical target in cancer therapy. The invention includes a nucleic acid encoding the antibody, a vector, and a host cell that can be utilized for producing the antibody. The pharmaceutical composition derived from this antibody has shown potential as an effective treatment for various cancers, demonstrating high affinity and specificity to mesothelin.
Another significant patent from Eun-Hee Lee is the "Anti-glypican 3 antibody and pharmaceutical composition containing the same." This invention focuses on an antibody that binds specifically to glypican 3 (GPC3), ideal for targeting hepatocellular carcinoma. The methodology outlined in this patent includes a nucleic acid encoding the antibody and techniques for antibody preparation, further enhancing its utility in cancer diagnostics and treatment.
Career Highlights: Eun-Hee Lee has amassed experience working with esteemed organizations in the biomedical field, notably the Mogam Institute for Biomedical Research and The Green Cross Corporation. Through these roles, he has engaged in transformative research aimed at advancing cancer treatment methodologies.
Collaborations: Throughout his career, Eun-Hee Lee has collaborated with talented professionals, including Dong-Sik Kim and Eun Jung Song. These partnerships have facilitated the development of sophisticated biomedical innovations, reinforcing the importance of teamwork in research and development.
Conclusion: Eun-Hee Lee's dedication to innovation in antibody development positions him as a key figure in the ongoing battle against cancer. His work not only exemplifies the spirit of invention but also has the potential to provide significant therapeutic benefits for patients battling cancer. As research continues to evolve, his contributions will undoubtedly remain influential in the biomedical community.